Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gary Lyons Insider Profile
4 Followers
Gary Lyons, Director at Neurocrine, holds 193.70K shares in Neurocrine (Ticker: NBIX), holds 0.00 shares in Eledon Pharmaceuticals (Ticker: ELDN), holds 75.00K shares in Rigel (Ticker: RIGL).
Profitable Transactions
3 out of 4 Profitable Transactions
Average Return
+24.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Gary Lyons holds in companies
Most Profitable Insider Trade
The most profitable trade made by Gary Lyons
Gary Lyons's Trading History
Neurocrine
Dec 27, 2023
Director
Uninformative Sell
1.30M
$26.93M
Eledon Pharmaceuticals
―
Director
―
$0.00
Travere Therapeutics
May 19, 2023
Director
Uninformative Buy
―
$303.49K
Fresh Tracks Therapeutics
Jan 05, 2021
Director
Uninformative Sell
4.65K
$17.62K
Plus Therapeutics
Jun 16, 2016
Director
Uninformative Buy
4.84K
$83.65K
Rigel
Jul 12, 2023
Director
Uninformative Buy
―
$74.40K
Humanigen
―
Director
―
$0.00
Neurogesx
―
―
―
$0.00
PDL BioPharma
―
―
―
$0.00
Poniard Pharmaceuticals
Jul 12, 2011
Director
Uninformative Buy
―
―
List of latest transactions for each holding click on a transaction to see Gary Lyons's performance on stock
You May Also Like
Gary Lyons insider profile FAQ
What is the percentage of profitable transactions made by Gary Lyons?
The percentage of profitable transactions made by Gary Lyons is 75%.
What is the average return per transaction made by Gary Lyons?
The average return per transaction made by Gary Lyons is 24.20%.
What stocks does Gary Lyons hold?
Gary Lyons holds: NBIX, ELDN, TVTX, FRTX, PSTV, RIGL, HGENQ, NGSX, PDLI, PARD stocks.
What was Gary Lyons’s latest transaction?
Gary Lyons latest transaction was an Uninformative Sell of $1.30M.
What was Gary Lyons's most profitable transaction?
Gary Lyons’s most profitable transaction was an Informative Buy of NBIX stock on February 15, 2017. The return on the trade was 101.50%.
What is Gary Lyons's role in Neurocrine?
Gary Lyons's role in Neurocrine is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.